[go: up one dir, main page]

YU33401A - 13-točlani azalidi i njihova primena kao antibiotičkih sredstava - Google Patents

13-točlani azalidi i njihova primena kao antibiotičkih sredstava

Info

Publication number
YU33401A
YU33401A YU33401A YU33401A YU33401A YU 33401 A YU33401 A YU 33401A YU 33401 A YU33401 A YU 33401A YU 33401 A YU33401 A YU 33401A YU 33401 A YU33401 A YU 33401A
Authority
YU
Yugoslavia
Prior art keywords
antibiotic agents
compounds
formula
relates
membered azalides
Prior art date
Application number
YU33401A
Other languages
English (en)
Inventor
Robert John Rafka
Barry James Morton
Colman Brendan Ragan
Peter Bertinato
John Philip Dirlam
Alan Elwood Blize
Carl Bernard Ziegler
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22327457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU33401(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU33401A publication Critical patent/YU33401A/sh
Publication of RS50302B publication Critical patent/RS50302B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Pronalazak se odnosi na postupak za pripremanje jedinjenja formula (1) i njihovih farmaceutski prihvatljivih soli. Pronalazak se takodje odnosi na farmaceutske kompozicije koje adrže jedinjenja formule (1) za lečenje infekcija izazvanih bakterijama i protozoama. Pronalazak se odnosi na postupke za pripremanje jedinjenja formule (1) i na medjurpoizvode koji su korisni za ova pripremanja.
YUP-334/01A 1998-11-20 1999-11-09 13-točlani azalidi i njihova primena kao antibiotičkih sredstava RS50302B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10939998P 1998-11-20 1998-11-20

Publications (2)

Publication Number Publication Date
YU33401A true YU33401A (sh) 2004-05-12
RS50302B RS50302B (sr) 2009-09-08

Family

ID=22327457

Country Status (46)

Country Link
US (1) US6329345B1 (sh)
EP (1) EP1131331B1 (sh)
JP (1) JP3842973B2 (sh)
KR (1) KR100477774B1 (sh)
CN (2) CN1326460A (sh)
AP (1) AP2001002142A0 (sh)
AR (3) AR019496A1 (sh)
AT (1) ATE260927T1 (sh)
AU (1) AU766106B2 (sh)
BG (1) BG65107B1 (sh)
BR (2) BRPI9915480B8 (sh)
CA (1) CA2351429C (sh)
CO (1) CO5380019A1 (sh)
CZ (1) CZ303099B6 (sh)
DE (1) DE69915336T2 (sh)
DK (1) DK1131331T3 (sh)
DZ (1) DZ2944A1 (sh)
EA (2) EA009729B1 (sh)
EG (1) EG23823A (sh)
ES (1) ES2216581T3 (sh)
GT (1) GT199900198A (sh)
HK (1) HK1041269A1 (sh)
HR (1) HRP20010374B1 (sh)
HU (1) HU229008B1 (sh)
ID (1) ID28548A (sh)
IL (3) IL142631A0 (sh)
IS (1) IS2350B (sh)
MA (1) MA26707A1 (sh)
ME (1) ME00467B (sh)
MY (1) MY122353A (sh)
NO (3) NO319796B1 (sh)
NZ (1) NZ511199A (sh)
OA (1) OA11713A (sh)
PA (1) PA8485601A1 (sh)
PE (1) PE20001378A1 (sh)
PL (1) PL198580B1 (sh)
PT (1) PT1131331E (sh)
RS (1) RS50302B (sh)
SI (1) SI1131331T1 (sh)
SK (1) SK284607B6 (sh)
TN (1) TNSN99214A1 (sh)
TW (2) TWI243825B (sh)
UA (1) UA70972C2 (sh)
UY (1) UY25805A1 (sh)
WO (1) WO2000031097A1 (sh)
ZA (1) ZA200104019B (sh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
KR20020016799A (ko) * 1999-05-24 2002-03-06 데이비드 존 우드 13-메틸-에리트로마이신 유도체
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
OA12257A (en) * 2000-04-27 2003-11-06 Pfizer Prod Inc the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
CA2529817C (en) * 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
RU2322241C2 (ru) * 2003-11-21 2008-04-20 Пфайзер Продактс Инк. Применение антибиотиков в качестве адъювантов вакцин
EP1985620A4 (en) * 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd COMPOUND 10a-AZALIDE
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
EP2619214B1 (en) * 2010-09-20 2014-12-24 Novartis AG Novel process for the preparation of 9-deoxo-9a-aza-9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
CN102295672B (zh) * 2011-07-13 2014-06-04 武汉回盛生物科技有限公司 一种泰拉菌素的合成方法
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
EP3027634B1 (en) * 2013-07-31 2018-03-21 Farma GRS, d.o.o. Process for preparation of tulathromycin
CN109748942A (zh) * 2014-05-16 2019-05-14 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
SG11202105227QA (en) * 2018-11-19 2021-06-29 Zikani Therapeutics Inc C10-alkylene substituted 13-membered macrolides and uses thereof
AU2019385383B2 (en) * 2018-11-19 2023-06-15 President And Fellows Of Harvard College C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
SI8611592A8 (en) * 1986-09-12 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-methyl-11-aza-10-deoxo-10-dihydroeritromicine A and 11-aza-10-deoxo-10-dihydroeritromicine A with metals
US5106961A (en) 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
GB2327084A (en) * 1997-07-08 1999-01-13 Merck & Co Inc 9a-Aza-3-ketolide antibiotics
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
ATE260927T1 (de) 2004-03-15
OA11713A (en) 2005-01-25
IS2350B (is) 2008-04-15
PL198580B1 (pl) 2008-06-30
IL189430A0 (en) 2008-06-05
CA2351429C (en) 2005-07-12
ME00467B (me) 2011-10-10
AR019496A1 (es) 2002-02-20
HK1041269A1 (zh) 2002-07-05
EG23823A (en) 2007-09-19
HUP0104313A3 (en) 2003-12-29
CZ20011754A3 (cs) 2002-03-13
CZ303099B6 (cs) 2012-04-04
DZ2944A1 (fr) 2004-03-15
DE69915336T2 (de) 2005-01-13
EA009729B1 (ru) 2008-02-28
PE20001378A1 (es) 2000-12-14
NO319796B1 (no) 2005-09-19
SK6632001A3 (en) 2002-07-02
BRPI9915480B1 (pt) 2015-12-29
CN1326460A (zh) 2001-12-12
AU766106B2 (en) 2003-10-09
HRP20010374A2 (en) 2002-06-30
TWI243825B (en) 2005-11-21
EA005156B1 (ru) 2004-12-30
ID28548A (id) 2001-05-31
IS5918A (is) 2001-04-17
PA8485601A1 (es) 2000-09-29
CO5380019A1 (es) 2004-03-31
RS50302B (sr) 2009-09-08
NO20012464D0 (no) 2001-05-18
WO2000031097A1 (en) 2000-06-02
MY122353A (en) 2006-04-29
UA70972C2 (uk) 2004-11-15
NO330249B1 (no) 2011-03-14
NO329629B1 (no) 2010-11-22
JP3842973B2 (ja) 2006-11-08
NO20050893L (no) 2001-07-17
BG65107B1 (bg) 2007-02-28
GT199900198A (es) 2001-05-11
ZA200104019B (en) 2002-06-17
EA200400701A1 (ru) 2004-12-30
KR20010086043A (ko) 2001-09-07
EA200100416A1 (ru) 2001-10-22
AR059524A2 (es) 2008-04-09
DE69915336D1 (de) 2004-04-08
NO20012464L (no) 2001-07-17
HRP20010374B1 (en) 2006-09-30
BRPI9915480B8 (pt) 2022-05-10
IL142631A (en) 2010-05-31
IL189430A (en) 2010-05-31
AP2001002142A0 (en) 2001-05-09
JP2002530422A (ja) 2002-09-17
IL142631A0 (en) 2002-03-10
NO20050904L (no) 2001-07-17
EP1131331B1 (en) 2004-03-03
MA26707A1 (fr) 2004-12-20
TW200404077A (en) 2004-03-16
BR9915480A (pt) 2001-07-31
NZ511199A (en) 2003-08-29
TNSN99214A1 (fr) 2005-11-10
PT1131331E (pt) 2004-06-30
DK1131331T3 (da) 2004-06-14
ES2216581T3 (es) 2004-10-16
HU229008B1 (en) 2013-07-29
TWI243824B (en) 2005-11-21
AR059523A2 (es) 2008-04-09
SK284607B6 (sk) 2005-07-01
SI1131331T1 (en) 2004-08-31
CN101367853A (zh) 2009-02-18
EP1131331A1 (en) 2001-09-12
BG105600A (en) 2001-12-29
AU1068600A (en) 2000-06-13
US6329345B1 (en) 2001-12-11
HUP0104313A2 (hu) 2002-02-28
KR100477774B1 (ko) 2005-03-21
CA2351429A1 (en) 2000-06-02
PL347784A1 (en) 2002-04-22
UY25805A1 (es) 2001-08-27

Similar Documents

Publication Publication Date Title
YU33401A (sh) 13-točlani azalidi i njihova primena kao antibiotičkih sredstava
EA199901014A1 (ru) C-4"-замещенные макролидные производные
BR9802851A (pt) Antibióticos de macrolìdeo substituìdos por c-4
TNSN98082A1 (fr) DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A.
CA2292359A1 (en) Novel azalides and methods of making same
EA200100623A1 (ru) Кетолидные антибиотики
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
EA199901016A1 (ru) 9-оксим-производные эритромицина
BR0010938A (pt) Derivados da 13-metil eritromicina
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
EA200100396A1 (ru) Новые макролидные антибиотики
CA2280328A1 (en) C11 carbamates of macrolide antibacterials
TNSN98196A1 (fr) Derives d'erythromycine tricycliques nouveaux, procede pour leur preparation et compositions les contenant
EA200001029A1 (ru) Производные гигромицина
TNSN98061A1 (fr) Derives d'erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
YU32601A (sh) Derivati higromicina kao antibakterijski agensi